| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Department of Physiology, Faculty of Medicine; and 2Department of Human Nutritional Sciences, Faculty of Human Ecology, Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre University of Manitoba, Winnipeg, Manitoba R2H 2A6, Canada
Submitted 24 November 2003 ; accepted in final form 8 March 2004
Volume overload due to arteriovenous (AV) shunt results in cardiac hypertrophy followed by the progression to heart failure. The phosphoinositide phospholipase C (PLC) converts phosphatidylinositol 4,5-bisphosphate (PIP2) to 1,2-diacylglycerol (DAG) and inositol (1,4,5)-trisphosphate (IP3), which are known to influence cardiac function. Therefore, we examined the time course of changes in DAG and IP3 as well as PLC isozyme gene expression, protein content, and activities in cardiac hypertrophy and heart failure induced by AV shunt in Sprague-Dawley rats by the needle technique. An increase in the left ventricle (LV)-to-body weight ratio demonstrated that LV hypertrophy was established at 4 wk after the induction of the shunt. PLC-
1 activity was increased two- and sevenfold at 3 days and 1 and 2 wk after the induction of volume overload, respectively. These changes were associated with increases in the mRNA and sarcolemmal (SL) protein content; however, no changes in PLC-1 were detected at 4 wk. On the other hand, a significant increase in PLC-
1 activity as well as mRNA and SL protein was seen at 3 days and 4 wk. A progressive decrease in PLC-
1 activity with concomitant reductions in the gene expression and SL protein abundance was detected during 1 to 4 wk. Activity of 1- and 1-isozymes was significantly depressed during the 8- and 16-wk time points, whereas 1-isozyme was increased significantly during these time points. A progressive decrease in the SL PIP2 content was observed during cardiac hypertrophy and heart failure. Our findings indicate that PLC isozyme signaling processes are increased in hypertrophy and decreased in heart failure due to volume overload.
cardiac sarcolemma; signal transduction
This article has been cited by other articles:
|
|
 |
|
  N. S. Dhalla, H. K. Saini-Chohan, D. Rodriguez-Leyva, V. Elimban, M. R. Dent, and P. S. Tappia Subcellular remodelling may induce cardiac dysfunction in congestive heart failure Cardiovasc Res, October 30, 2008; (2008) cvn281v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Peng, E Shen, J. Fan, Y. Zhang, J. M. O. Arnold, and Q. Feng Disruption of phospholipase C{gamma}1 signalling attenuates cardiac tumor necrosis factor-{alpha} expression and improves myocardial function during endotoxemia Cardiovasc Res, April 1, 2008; 78(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shimokawa, H. Yokoshiki, and H. Tsutsui Impaired activation of ATP-sensitive K+ channels in endocardial myocytes from left ventricular hypertrophy Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3643 - H3649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mangat, T. Singal, N. S. Dhalla, and P. S. Tappia Inhibition of phospholipase C-{gamma}1 augments the decrease in cardiomyocyte viability by H2O2 Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H854 - H860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Lien, T. Noel, H. Liu, A. J. Stromberg, K.-C. Chen, and D. K. St. Clair Phospholipase C-{delta}1 Is a Critical Target for Tumor Necrosis Factor Receptor-Mediated Protection against Adriamycin-Induced Cardiac Injury. Cancer Res., April 15, 2006; 66(8): 4329 - 4338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Tappia, M. S. Nijjar, A. Mahay, N. Aroutiounova, and N. S. Dhalla Phospholipid profile of developing heart of rats exposed to low-protein diet in pregnancy Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1400 - R1406. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
